Stay updated on Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new citation entry is added under Publications for a 2025 Alzheimer’s Dement paper by Devanarayan V, Ye Y, Zhu L, Tian L, Kramer L, Irizarry M, and Dhadda S, describing prognostic covariates in lecanemab trials. This update broadens the study's scholarly context and points readers to recent research related to natural progression in early Alzheimer’s disease.
    Difference
    0.0%
    Check dated 2026-05-25T07:54:11.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.4) was added and the previous tag (v3.5.3) removed, indicating an internal update to the page's versioning or template.
    Difference
    0.0%
    Check dated 2026-05-18T03:56:48.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Malmo, Sweden was removed and Malmö, Sweden was added in the Locations list, updating the Sweden entry to the correct local spelling.
    Difference
    0.0%
    Check dated 2026-05-03T19:38:50.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page footer’s software/version label was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” indicating a platform release rather than a change to the underlying trial information.
    Difference
    0.0%
    Check dated 2026-04-26T15:15:46.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The revision tag on the page was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T08:54:02.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added official results data and expanded safety/efficacy endpoints for core and extension phases, including ADCOMS, CDR-SB, ADAS-Cog, CSF biomarkers, MRI volumetrics, and amyloid PET measures; TEAEs/SAEs definitions and the Results First Posted date are now included.
    Difference
    2%
    Check dated 2026-03-06T21:03:51.000Z thumbnail image

Stay in the know with updates to Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.